NAIMES/32 – A randomized double-blind, placebo controlled study to assess the safety and the efficacy of Neridronate ampoules 25 mg, after repeated intramuscular administration, in patients with complex Regional Pain Syndrome type 1 (CRPS-1)

  1. Home
  2. Research
  3. Projects
  4. NAIMES/32 – A randomized double-blind, placebo controlled study to assess the safety and the efficacy of Neridronate ampoules 25 mg, after repeated intramuscular administration, in patients with complex Regional Pain Syndrome type 1 (CRPS-1)
Starting date
June 9, 2015
Duration (months)
60
Departments
Medicine
Managers or local contacts
Gatti Davide

Project participants

Davide Gatti
Associate Professor
Research areas involved in the project
Rheumatology  (DM)
Rheumatology  (DNBM)

Activities

Research facilities

Share